Neogenomics Inc.
NASDAQ:NEO
| Market Cap (Intraday) | 905.64M |
| Current PE | N/A |
| Forward PE | 48.4 |
| 2yr Forward PE | 24.2 |
| 10-Day MA | $7.37 |
| 50-Day MA | $7.49 |
| 200-Day MA | $11.98 |
Neogenomics Inc. Stock, NASDAQ:NEO
9490 NeoGenomics Way, Suite 9, Fort Myers, Florida 33912
United States of America
Phone: +1.239.768.0600
Number of Employees: 2200
Description
NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.